About this trial
Pilonidal sinus disease is a common condition, and treatment options and outcomes vary greatly. Chronic symptomatic pilonidal sinus disease (PSD) primarily affects young adults and causes work loss. In this study, three treatment methods will be performed: the minimally invasive pit-picking procedure, crystallized phenol application (CPT), and a combined method (minimally invasive pit-picking procedure and CPT). The aim of this study is to compare the effectiveness of these three methods, evaluate short- and long-term results, and determine treatment success, the incidence of postoperative complications, chronic pain levels, recurrence rates, and patient satisfaction. Additionally, the effects of these methods on hospital stay, wound healing time, and workforce loss will also be examined.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having two pits or less
Disqualifiers
With bilateral lateral extension,
Stage-R with recurrent disease
Number of pits more than three pits,
Collagen tissue disease,
Trial population
Female patients aged 18 and older with pilonidal sinus disease and two or fewer pits, with no previous surgical treatment.
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Treatment Success
The primary outcome measure will evaluate the effectiveness of three different treatment methods for pilonidal sinus disease: Pit Picking, Crystallized Phenol (CPT) Application, and Combined Pit Picking and CPT Application. Effectiveness will be determined by the absence of disease recurrence and complete healing.
Postoperative Complications
This measure will assess the incidence of postoperative complications such as infection and pain.
Secondary outcomes
Recurrence Rate
Evaluation of the rate of disease recurrence after treatment.
Chronic Pain Level
Assessment of chronic pain levels in patients following treatment using the Visual Analog Scale (VAS). VAS is a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. Higher scores indicate worse outcomes.
Patient Satisfaction
Measurement of patient satisfaction with the treatment process and outcomes using the Patient and Observer Scar Assessment Scale (POSAS). POSAS is a scale from 1 to 10, where 1 represents the best outcome and 10 represents the worst outcome. Higher scores indicate worse outcomes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.